Aim of this study is to determine and compare the efficacy of green tea extract on inflammatory markers including IL 1β, IL 6, CRP, TNF α, total antioxidant capacity (TAC), MDA and severity of the disease in lupus patients in two groups of intervention and control . This study is a randomized, double-blind clinical trial. The subjects are systemic lupus erythematous patients. This study is in the second phase of clinical trial. The subjects are patients older than 15 years who have had 4 diagnosis criteria’s of lupus. These include clinical and immunological criteria's. Study participants were randomly divided into 2 groups of intervention( capsules of green tea extract) and control group (capsule of cellulose). Exclusion criteria are as follow: patients with other autoimmune diseases; infectious or liver disease; patients with creatinine higher than 2.5 and the women who are pregnant. The sample were found to be 76. The patients in intervention group are given daily dose of 1000mg of aqueous green tea extract (of 6 gram of dried green tea leaf) in form of two capsules ( 500 mg). Also in control group, the patients are given daily dose of 1000mg of cellulose in form of two capsules ( 500 mg). Duration of treatment is three months. Measured variables at baseline and after 12 weeks include Inflammatory factors ( IL 6, IL 1β , TNF α), CRP, MDA, serum total antioxidant capacity(TAC) and disease activity.